Abstract
This chapter illustrates diseases that involve the peripheral nervous system and skeletal muscle. In such diseases, the history and physical examination frequently provide sufficient data to arrive at the correct diagnosis. For example, autonomic dysfunction, distal limb weakness, hyporeflexia, and sensory loss in an adult with long-standing diabetes mellitus are probably due to diabetic neuropathy, and fluctuating weakness of bulbar and ocular muscles without sensory or reflex alterations strongly suggests myasthenia gravis. The clinical diagnosis can often be validated by specific immunochemical, biochemical, or molecular blood tests (Fig. 11-1).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hermann DN, Griffin JW, Hauer P, et al.: Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies. Neurology 1999, 53:1634–1640.
Asbury AK, Gilliatt RW: The Clinical Approach to Neuropathy. In Peripheral Nerve Disorders. Edited by Asbury AK, Gilliatt RW. London: Butterworths; 1994: 1–20.
Lennon VA, Kryzer TJ, Griesmann GE, et al.: Calcium channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995, 332:1467–1474.
Chaudhry V, Crawford TO: Stimulation single-fiber EMG in infant botulism. Muscle Nerve 1999, 22: 1698–1703.
Pasternak C, Wong S, Elson EL: Mechanical function of dystrophin in muscle cells. J Cell Biol 1995, 128: 355–361.
Chan YM, Bonnemann CG, Lidov HGM, Kunkel LM: Molecular organization of sarcoglycan complex in mouse myotubes in culture. J Cell Biol 1998, 143: 2033–2044.
Mahadevan M, Tsilfidis C, Sabourin L, et al.: Myotonic dystrophy mutation: an unstable CTG repeat in the 3’ untranslated region of the gene. Science 1992, 255:1253–1255.
Lieberman AP, Fischbeck KH: Triplet repeat expansion in neuromuscular disease. Muscle Nerve 2000, 23: 843–850.
DiMauro S, Bonilla E, Davidson M, et al.: Mitochondria in neuromuscular disorders. Biochim Biophys Acta 1998, 1366:199–210.
Laing NG, Wilton SD, Akkari PA, et al.: A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nature Genet 1995, 9:75–79.
Johnston JJ, Kelley RI, Crawford TO, et al.: A novel nemaline myopathy in the Amish caused by a mutation in troponin TL. Am J Hum Genet 2000, 67:814–821.
McCarthy TV, Quane KA, Lynch PJ: Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 2000, 15: 410–417.
Sigurgeirsson B, Lindelof B, Edhag O, Allander E: Risk of cancer in patients with dermatomyositis or polymyositis: a population-based study. N Engl J Med 1992, 326: 363–367.
Askanas V, Engel WK: Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: current concepts of diagnosis and pathogenesis. Curr Opin Rheumatol 1998, 10: 530–542.
Adams D, Samuel D, Goulon-Goeau C, et al.: The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000, 123:1495–1504.
Keller MP, Chance PF: Inherited neuropathies: from gene to disease. Brain Pathol 1999, 9: 327–341.
La Spada AR, Roling DB, Harding AE, et al.: Meiotic stability and genotype-phenotype correlation of the ‘trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nature Genet 1992, 2:301–304.
Pellizzoni L, Charroux B, Dreyfuss G: SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins. Proc Natl Acad Sci USA 1999, 96: 11167–111672.
Gurney ME, Liu R, Althaus JS, et al.: Mutant CuZn superoxide dismutase in motor neuron disease. J Inherit Metab Dis 1998; 21:587–597.
Peters A, Palay SL, Webster H deF: The Fine Structure of the Nervous System. New York: Oxford University Press; 1994.
Khella SL, Frost S, Hermann GA, et al.: Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alpha: case report and literature review. Neurology 1995, 45:407–411.
Rajkumar SV, Gertz MA, Kyle RA: Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 1998, 104: 232–237.
Arroyo EJ, Scherer SS: On the molecular architecture of myelinated fibers. Histochem Cell Biol 2000, 113: 1–18.
Nobile-Orazio E, Meucci N, Baldini L, et al.: Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 2000, 123:710–717.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pleasure, D., Bird, S., Scherer, S., Sladky, J., Schotland, D. (2003). Neuromuscular Disease. In: Rosenberg, R.N. (eds) Atlas of Clinical Neurology. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4552-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4552-8_11
Publisher Name: Current Medicine Group, London
Print ISBN: 978-1-4757-4554-2
Online ISBN: 978-1-4757-4552-8
eBook Packages: Springer Book Archive